Patents Assigned to Ralexar Therapeutics, Inc.
  • Patent number: 10246419
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of LXR-associated diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: April 2, 2019
    Assignee: RALEXAR THERAPEUTICS, INC.
    Inventor: Raju Mohan
  • Patent number: 10047055
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of LXR-associated diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: August 14, 2018
    Assignee: Ralexar Therapeutics, Inc.
    Inventor: Raju Mohan
  • Patent number: 9981913
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: May 29, 2018
    Assignee: Ralexar Therapeutics, Inc.
    Inventor: Raju Mohan
  • Patent number: 9637481
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: May 2, 2017
    Assignee: Ralexar Therapeutics, Inc.
    Inventor: Raju Mohan